Predictions
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
04.08.20
04.08.20
€38.00
04.11.21
04.11.21
0.31%
13.04.21
13.04.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Achieve Life Sciences Inc.
Start price
Target price
Perf. (%)
€9.61
31.07.20
31.07.20
-
04.11.21
04.11.21
-19.91%
05.11.21
05.11.21
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€89.92
30.07.20
30.07.20
€125.00
04.11.21
04.11.21
44.97%
21.01.21
21.01.21
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€110.70
27.07.20
27.07.20
-
04.11.21
04.11.21
50.84%
05.11.21
05.11.21
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
High valuation
Lannett Co. Inc.
Start price
Target price
Perf. (%)
€21.89
16.07.20
16.07.20
€120.00
04.11.21
04.11.21
-63.45%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.70
16.07.20
16.07.20
€33.21
25.08.20
25.08.20
4.15%
25.08.20
25.08.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€3.18
15.07.20
15.07.20
-
01.08.20
01.08.20
-36.48%
01.08.20
01.08.20
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€3.62
14.07.20
14.07.20
-
15.07.20
15.07.20
-12.15%
15.07.20
15.07.20
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Ipsen S.A.
Start price
Target price
Perf. (%)
€81.00
13.07.20
13.07.20
€95.00
04.11.21
04.11.21
12.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.65
12.07.20
12.07.20
-
17.10.20
17.10.20
9.93%
17.10.20
17.10.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Purple Biotech Ltd. ADR
Start price
Target price
Perf. (%)
€7.10
11.07.20
11.07.20
€6.00
04.11.21
04.11.21
-43.38%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Biocorp Production S.A.
Start price
Target price
Perf. (%)
€25.90
09.07.20
09.07.20
€25.00
04.11.21
04.11.21
11.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.84
01.07.20
01.07.20
€42.69
08.07.20
08.07.20
-2.30%
08.07.20
08.07.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Baxter International
Start price
Target price
Perf. (%)
€77.61
01.07.20
01.07.20
€80.00
04.11.21
04.11.21
-12.10%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
Inovio Pharma
Start price
Target price
Perf. (%)
€25.80
30.06.20
30.06.20
-
04.11.21
04.11.21
-72.73%
17.06.21
17.06.21
Probably not worthwhile Investment